Shukra Pharmaceuticals Limited

BSE:524632 Stock Report

Market Cap: ₹3.3b

Shukra Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.


Ownership Breakdown

What is the ownership structure of 524632?
Owner TypeNumber of SharesOwnership Percentage
General Public925.8218,46 %
Individual Insiders4.795.77543,8 %
Private Companies5.225.39047,7 %

Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr nicht nennenswert verwässert.


Top Shareholders

Top 11 shareholders own 91.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19,2 %
Renuka Parikh
2.100.000₹632.7m0 %no data
19,2 %
Yogesh Parikh
2.100.000₹632.7m0 %no data
18,8 %
Anar Project Ltd
2.056.000₹619.5m0 %no data
17,2 %
Parshva Texchem (I) Pvt Ltd
1.879.390₹566.3m0 %no data
11,8 %
Navkar Surgical Gujarat Ltd
1.290.000₹388.7m0 %no data
1,86 %
Kailashben Patel
203.490₹61.3m0 %no data
1 %
Dakshesh Shah
109.000₹32.8m0 %no data
1 %
Anar Patel
109.000₹32.8m0 %no data
0,71 %
Sujay Mehta
78.000₹23.5m0 %no data
0,52 %
Payalben Mehta
57.000₹17.2m0 %no data
0,36 %
Rajeshkumar Patel
39.285₹11.8m0 %no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.